Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 129683, 5 pages
http://dx.doi.org/10.1155/2014/129683
Research Article

Evaluation of Clinical Contributions Provided by Addition of the Brain, Calvarium, and Scalp to the Limited Whole Body Imaging Area in FDG-PET/CT Tumor Imaging

1Department of Nuclear Medicine, Faculty of Medicine, Dicle University, 21280 Diyarbakir, Turkey
2Department of Medical Oncology, Faculty of Medicine, Dicle University, 21280 Diyarbakir, Turkey
3Department of Nuclear Medicine, Faculty of Medicine, Izmir University, 35575 Izmir, Turkey
4Department of Nuclear Medicine, Elazig Training and Research Hospital, 23200 Elazig, Turkey

Received 17 February 2014; Accepted 28 May 2014; Published 16 June 2014

Academic Editor: David J. Yang

Copyright © 2014 Bekir Tasdemir et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Delbeke, R. E. Coleman, M. J. Guiberteau et al., “Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0,” Journal of Nuclear Medicine, vol. 47, no. 5, pp. 885–895, 2006. View at Google Scholar · View at Scopus
  2. N. Avril, “GLUT1 expression in tissue and 18F-FDG uptake,” Journal of Nuclear Medicine, vol. 45, no. 6, pp. 930–932, 2004. View at Google Scholar · View at Scopus
  3. G. Abikhzer, Y. Z. Alabed, L. Azoulay, J. Assayag, and C. Rush, “Altered hepatic metabolic activity in patients with hepatic steatosis on FDG PET/CT,” American Journal of Roentgenology, vol. 196, no. 1, pp. 176–180, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. M. M. Osman, B. T. Chaar, R. Muzaffar et al., “18F-FDG PET/CT of patients with cancer: comparison of whole-body and limited whole-body technique,” American Journal of Roentgenology, vol. 195, no. 6, pp. 1397–1403, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Boellaard, M. J. O'Doherty, W. A. Weber et al., “FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 37, no. 1, pp. 181–200, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. “ACR-SPR practice guideline for performing FDG-PET/CT in oncology,” American College of Radiology, 2014, http://www.acr.org/~/media/71B746780F934F6D8A1BA5CCA5167EDB.pdf.
  7. S. F. Huston, A. G. Abdelmalik, N. C. Nguyen, H. R. Farghaly, and M. M. Osman, “Whole-body18F-FDG PET/CT: the need for a standardized field of view-a referring-physician aid,” Journal of Nuclear Medicine Technology, vol. 38, no. 3, pp. 123–127, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. A. G. Abdelmalik, S. Alenezi, R. Muzaffar, and M. M. Osman, “The incremental added value of including the head in (18) F-FDG PET/CT imaging for cancer patients,” Frontiers in Oncology, vol. 3, article 71, 2013. View at Google Scholar
  9. H. Y. Lee, K. S. Lee, B.-T. Kim et al., “Diagnostic efficacy of PET/CT plus brain MR imaging for detection of extrathoracic metastases in patients with lung adenocarcinoma,” Journal of Korean Medical Science, vol. 24, no. 6, pp. 1132–1138, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. N. C. Nguyen, B. T. Chaar, and M. M. Osman, “Prevalence and patterns of soft tissue metastasis: detection with true whole-body F-18 FDG PET/CT,” BMC Medical Imaging, vol. 7, article 8, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Sebro, C. Mari-Aparici, and M. Hernandez-Pampaloni, “Value of true whole-body FDG-PET/CT scanning protocol in oncology: optimization of its use based on primary diagnosis,” Acta Radiologica, vol. 54, no. 5, pp. 534–539, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Bochev, A. Klisarova, A. Kaprelyan, B. Chaushev, and Z. Dancheva, “Brain metastases detectability of routine whole body 18F-FDG PET and low dose CT scanning in 2502 asymptomatic patients with solid extracranial tumors,” Hellenic Journal of Nuclear Medicine, vol. 15, no. 2, pp. 125–167, 2012. View at Google Scholar · View at Scopus
  13. K. Kitajima, Y. Nakamoto, H. Okizuka et al., “Accuracy of whole-body FDG-PET/CT for detecting brain metastases from non-central nervous system tumors,” Annals of Nuclear Medicine, vol. 22, no. 7, pp. 595–602, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. E. M. Rohren, J. M. Provenzale, D. P. Barboriak, and R. E. Coleman, “Screening for cerebral metastases with FDG PET in patients undergoing whole-body staging of non-central nervous system malignancy,” Radiology, vol. 226, no. 1, pp. 181–187, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. K. E. Posther, L. M. McCall, D. H. Harpole Jr. et al., “Yield of brain18F-FDG PET in evaluating patients with potentially operable non-small cell lung cancer,” Journal of Nuclear Medicine, vol. 47, no. 10, pp. 1607–1611, 2006. View at Google Scholar · View at Scopus
  16. L. J. Schouten, J. Rutten, H. A. M. Huveneers, and A. Twijnstra, “Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma,” Cancer, vol. 94, no. 10, pp. 2698–2705, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. J. S. Barnholtz-Sloan, A. E. Sloan, F. G. Davis, F. D. Vigneau, P. Lai, and R. E. Sawaya, “Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System,” Journal of Clinical Oncology, vol. 22, no. 14, pp. 2865–2872, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. I. T. Gavrilovic and J. B. Posner, “Brain metastases: epidemiology and pathophysiology,” Journal of Neuro-Oncology, vol. 75, no. 1, pp. 5–14, 2005. View at Publisher · View at Google Scholar · View at Scopus